Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Etonogestrel 68mg implant |
| BNF code | 0703022P0AAAAAA |
| Virtual Therapeutic Moiety | Etonogestrel |
| Date identifier became valid | 26 May 2021 |
| Previous product identifier | 326452007 |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | device |
| Unit dose unit of measure | device |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Etonogestrel |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 68.000 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | implant.subcutaneous |
| Dose Form | |
| Formulation | Prolonged-release subcutaneous implant |
| Drug Route | |
| Route | Subcutaneous |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Nexplanon 68mg implant (Organon Pharma (UK) Ltd) | |
| Virtual Medicinal Product Packs | |
| Etonogestrel 68mg implant 1 device | |
dm+d data retrieved from TRUD: release NHSBSA_4.2.0_20240415000001, imported on 15th April 2024 at 05:09:22.